MARKET REPORT: Indivior shares dive as it axes schizophrenia drug
By John Abiona Updated: 17:01 EDT, 9 July 2024 Shares in Indivior hit a three-year low after dropping one of its schizophrenia drugs and warning profits will be worse than hoped. The pharma company, whose shares still trade in London despite it shifting …